30182 Federal Register / Vol. 83, No. 124 / Wednesday, June 27, 2018 / Notices 

• Creating a more efficient review 

strategy for evaluating qualified health 

claims on food labels. 

• Discussing new or enhanced 

labeling statements or claims that could 

facilitate innovation to produce more 

healthful foods and more healthful 

consumer food choices. 

• Modernizing the standards of 

identity to provide more flexibility for 

the development of healthier products, 

while making sure consumers have 

accurate information about these food 

products. 

• Providing opportunities to make 

ingredient information more helpful to 

consumers. 

• FDA’s educational campaign for 

consumers about the updated Nutrition 

Facts Label. 

We invite interested parties to provide 

information on the above and other 

topics related to the FDA Nutrition 

Innovation Strategy. 

III. Participating in the Public Meeting 

Registration: To register for the public 

meeting, please visit the following 

website: https://www.fda.gov/Food/ 

NewsEvents/WorkshopsMeetings

Conferences/default.htm. Please provide 

complete contact information for each 

attendee, including name, title, 

affiliation, address, email, and 

telephone. 

Registration is free and based on 

space availability, with priority given to 

early registrants. Persons interested in 

attending this public meeting must 

register by July 19, 2018, midnight 

Eastern Time. Early registration is 

recommended because seating is 

limited; therefore, FDA may limit the 

number of participants from each 

organization. Registrants will receive 

confirmation when they have been 

accepted. 

If you need special accommodations 

due to a disability, please contact 

Juanita Yates (see FOR FURTHER

INFORMATION CONTACT) no later than July 

12, 2018. 

Requests for Oral Presentations: 

During online registration you may 

indicate if you wish to present during a 

public comment session or participate 

in a specific session, and which topic(s) 

you wish to address. We will do our 

best to accommodate requests to make 

public comments and requests to 

participate in the focused sessions. 

Individuals and organizations with 

common interests are urged to 

consolidate or coordinate their 

presentations, and request time for a 

joint presentation, or submit requests for 

designated representatives to participate 

in the focused sessions. All requests to 

make oral presentations must be 

received by July 12, 2018, midnight 

Eastern Time. We will determine the 

amount of time allotted to each 

presenter and the approximate time 

each oral presentation is to begin, and 

will select and notify participants by 

July 16, 2018. Speakers will be limited 

to making oral remarks; there will not be 

an opportunity to display materials such 

as slide shows, videos, or other media 

during the meeting. No commercial or 

promotional material will be permitted 

to be presented or distributed at the 

public meeting. 

Streaming Webcast of the Public 

Meeting: This public meeting will also 

be webcast. Webcast participants are 

asked to preregister at https://

www.fda.gov/Food/NewsEvents/ 

WorkshopsMeetingsConferences/ 

default.htm. 

Transcripts: Please be advised that as 

soon as a transcript of the public 

meeting is available, it will be accessible 

at https://www.regulations.gov. It may 

be viewed at the Dockets Management 

Staff (see ADDRESSES). A link to the 

transcript will also be available on the 

internet at https://www.fda.gov/Food/ 

NewsEvents/WorkshopsMeetings

Conferences/default.htm. 

Other Issues for Consideration: A 

summary of key information on 

participating in the meeting follows: 

TABLE 1—INFORMATION ON PARTICIPATION IN THE MEETING

Date Address Preregister Electronic address Request to make 

an oral presentation 

Special 

accommodations 

Submit either electronic or 

written comments 

July 26, 2018 from 

8:30 a.m. until 

5:30 p.m. EDT.

Hilton Washington 

DC/Rockville 

Hotel, 1750 

Rockville Pike, 

Rockville, MD 

20852.

July 19, 2018: Closing date for registration.https://www.fda.gov/ 

Food/ 

NewsEvents/ 

WorkshopsMeetingsConferences/ 

default.htm.

July 12, 2018 ......... July 12, 2018: closing date to request special accommodations 

due to a disability.

Submit Comments to: https://

www.regulations.gov, or 

Dockets Management Staff 

(HFA–305), Food and Drug 

Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. 

Dated: June 22, 2018. 

Leslie Kux, 

Associate Commissioner for Policy. 

[FR Doc. 2018–13831 Filed 6–26–18; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Meeting of the Tick-Borne Disease 

Working Group 

AGENCY: Office of HIV/AIDS and 

Infectious Disease Policy, Office of the 

Assistant Secretary for Health, Office of 

the Secretary, Department of Health and 

Human Services. 

ACTION: Notice. 

SUMMARY: The Department of Health and 

Human Services (HHS) announces the 

seventh meeting of the Tick-Borne 

Disease Working Group (Working 

Group) on July 24, 2018, from 10:00 a.m. 

to 4:00 p.m., Eastern Time. The seventh 

meeting will be an on-line meeting held 

via webcast. The Working Group will 

review and vote on the content of the 

five chapters that will be included in 

the Working Group’s Report to 

Congress. 

DATES: The on-line meeting will be held 

on July 24, 2018, from 10:00 a.m. to 4:00 

p.m. Eastern Time. 

ADDRESSES: This will be an on-line 

meeting that is held via webcast. 

Members of the public may attend the 

meeting via webcast. Instructions for 

attending this virtual meeting will be 

posted prior to the meeting at: https:// 

www.hhs.gov/ash/advisory-committees/ 

tickbornedisease/meetings/index.html. 

FOR FURTHER INFORMATION CONTACT: 

James Berger, Office of HIV/AIDS and 

Infectious Disease Policy, Office of the 

Assistant Secretary for Health, 

Department of Health and Human 

Services; via email at tickbornedisease@

hhs.gov or by phone at 202–795–7697. 

SUPPLEMENTARY INFORMATION: The 

Working Group invites public comment 

on issues related to the Working Group’s 

charge. Comments may be provided 

over the phone during the meeting or in 

writing. Persons who wish to provide 

comments by phone should review 

directions at https://www.hhs.gov/ash/ 

advisory-committees/tickbornedisease/ 

meetings/index.html before submitting a 

request via email at tickbornedisease@

hhs.gov on or before July 19, 2018. 


daltland on DSKBBV9HB2PROD with NOTICES
Federal Register / Vol. 83, No. 124 / Wednesday, June 27, 2018 / Notices 30183 

Phone comments will be limited to 

three minutes each to accommodate as 

many speakers as possible. A total of 30 

minutes will be allocated to public 

comments. If more requests are received 

than can be accommodated, speakers 

will be randomly selected. The nature of 

the comments will not be considered in 

making this selection. Public comments 

may also be provided in writing. 

Individuals who would like to provide 

written comment should review 

directions at https://www.hhs.gov/ash/ 

advisory-committees/tickbornedisease/ 

meetings/index.html before sending 

their comments to tickbornedisease@

hhs.gov on or before July 19, 2018. 

During the meeting, the Working 

Group will review and vote on the 

content of the five draft chapters that 

will be included in the Working Group’s 

Report to Congress. Persons who wish to 

receive the draft chapters should email 

the tickbornedisease@hhs.gov and 

request a copy. The chapters will be 

available prior to the meeting. 

Background and Authority: The TickBorne Disease Working Group was 

established on August 10, 2017, in 

accordance with section 2062 of the 21st 

Century Cures Act, and the Federal 

Advisory Committee Act, 5 U.S.C. App., 

as amended, to provide expertise and 

review all HHS, DoD and VA efforts 

related to tick-borne diseases to help 

ensure interagency coordination and 

minimize overlap, examine research 

priorities, and identify and address 

unmet needs. In addition, the Working 

Group is required to submit a report to 

the Secretary and Congress on their 

findings and any recommendations for 

improving the federal response to tickborne disease prevention, treatment and 

research, and addressing gaps in those 

areas. 

Dated: June 22, 2018. 

James Berger, 

Designated Federal Officer, Office of HIV/ 

AIDS and Infectious Disease Policy, TickBorne Disease Working Group. 

[FR Doc. 2018–13812 Filed 6–26–18; 8:45 am] 

BILLING CODE 4150–28–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Eunice Kennedy Shriver National 

Institute of Child Health & Human 

Development; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel; Multiple Study Data 

Coordinating Centers for Division of 

Intramural Population Health Research 

(DIPHR). 

Date: July 30, 2018. 

Time: 1:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 6710 B 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Sathasiva B. Kandasamy, 

Ph.D., Scientific Review Administrator, 

Division of Scientific Review. National 

Institute of Child Health and Human 

Development, 6710B Rockledge Drive, 

Bethesda, MD 20892, (301) 435–6680, 

skandasa@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS) 

Dated: June 21, 2018. 

Michelle D. Trout, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–13788 Filed 6–26–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Eye Institute; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Eye Institute 

Special Emphasis Panel; NEI Pathways To 

Independence (K99) and Conference (R13) 

Grant Applications. 

Date: July 23–24, 2018. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 5635 

Fishers Lane, Bethesda, MD 20892. 

Contact Person: Zhihong Shan, MD, Ph.D., 

Scientific Review Officer (Contractor), 

Division of Extramural Activities, National 

Eye Institute, National Institute of Health, 

5635 Fishers Lane, Suite 1300, Bethesda, MD 

20892, 301–435–1779, zhihong.shan@

nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.867, Vision Research, 

National Institutes of Health, HHS) 

Dated: June 22, 2018. 

Natasha M. Copeland, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–13844 Filed 6–26–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Complementary & 

Integrative Health; Notice of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Advisory 

Council for Complementary and 

Integrative Health. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Council for Complementary and Integrative 

Health. 

Date: August 15, 2018. 

Closed: 1:00 p.m. to 2:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy 

Boulevard, Bethesda, MD 20892, (Virtual 

Meeting). 

Contact Person: Partap Singh Khalsa, 

Ph.D., DC, Director, Division of Extramural 

Activities, National Center for 


daltland on DSKBBV9HB2PROD with NOTICES